IRSantPau - Institut de Recerca Sant Pau

LS (Life Sciences)
GINYS Group: High

ADDRESS

Sant Quintí, 77-79

08041 Barcelona

WEBSITES

OTHER LINKS

Responsable(s)

Jordi Virgili | jvirgili@santpau.cat | +34 93 553 78 68

QUALITY CONTROL

Code of Conduct CERCA
The CERCA Code of Conduct, aligned with the European Code of Conduct for Research Integrity, recognized by the European institutions, provides guarantees in terms of transparency, open access to data and results, industrial property management, scientific integrity and relationship with the media, among others.
Status: Active
HRS4R
Human Resource Strategy for Researchers It supports research institutions and funding organizations in implementing the Charter and Code in their policies and practices. The implementation of the Charter and Code principles by research institutions makes them more attractive to researchers looking for a new employer or host for their research project..
Status: Active

INSTITUTE NETWORKS

EATRIS – EUROPEAN INFRASTRUCTURE FOR TRANSLATIONAL MEDICINE (ESFRI)
European infrastructure for translational medicine. We pool resources and services for research communities to translate scientific discoveries into benefits for patients.
Range: Europe
Status: Active
Funding: EU
ECRIN – European Clinical Research Infrastructure Network (ESFRI)
Vision & Mission: All Medical Practice Based on Scientific Evidence ECRIN's vision is to generate scientific evidence to optimise medical practice. To achieve this vision, ECRIN supports the conduct of multinational clinical research in Europe (i.e. its vision). By managing and supporting clinical trials across borders, connecting networks, and advising and implementing policy, ECRIN advances knowledge flow, competitiveness and integration in European clinical research.
Range: Worldwide
Status: Active
Funding: EU
BiB – Bioinformatics Network of Catalonia

Bioinformatics Barcelona (BIB) is an association for the provision of education and training, the promotion of advanced research, the transfer of knowledge and technology, the stimulation of competitiveness and innovation in the industrial sector, and the provision of 'greater visibility as an international entity. BIB was born to cover the need to generate synergies between biology and computer science, for a stronger union between these areas and for the development of high quality education and training programs in the creation of bioinformatics talent.

Range: Catalonia
Status: Active
ProMed – Proteomic Platform
The Center for Genomic Regulation (CRG) has partnered with several leading hospital research institutes in Catalonia to create a new state-of-the-art infrastructure to study and analyze proteins. It is the first such collaboration between biomedical research institutes and hospitals. The state-of-the-art equipment acquired will help meet the growing demand for protein analysis from Catalan research and innovation institutions.
Range: Catalonia
Status: Active
CIBER-BBN – Bioengineering, Biomaterials and Nanomedicine
Mission: Carry out research of excellence aimed at transfer to industry and clinical translation through the development of the scientific areas of bioengineering, biomaterials and nanomedicine.  
Range: Spain
Status: Active
CIBER-BBN NANBIOSIS – NANBIOSIS Platform (Production Infrastructure and Characterization of Nanomaterials, Biomaterials and Systems in Biomedicine) (ICTS)
Mission: Provide advanced comprehensive solutions for companies and research institutions under a single point of entry through the design and production of biomaterials, nanomaterials and their nanoconjugates, their characterization from the physical-chemical, functional, toxicological and biological point of view ( preclinical validation), focused on biomedical applications such as: IVD, medical devices, biosensors, regenerative medicine, drug delivery systems, therapeutic agents, or magnetic resonance contrast agents.
Range: Spain
Status: Active
CIBEREHD – Liver and Digestive Diseases
Mission: CIBEREHD is a consortium with its own legal personality, without physical contiguity, which aims to promote and collaborate in scientific research, development of knowledge and its transfer to society, in the area of ​​liver and digestive diseases.
Range: Spain
Status: Active
CIBERER – Rare Diseases
Mission:Our mission is to be a center where collaboration and cooperation between biomedical and clinical research groups prevail and are favored, with special emphasis on the aspects of genetic, molecular, biochemical and cell research. of rare, genetic or acquired diseases. The aim is to improve our knowledge of the epidemiology, causes and production mechanisms of rare diseases. This research is the basis for providing new tools for the diagnosis and therapy of rare diseases, encouraging translational or translational research between the scientific environment of the laboratory and the clinical environment of health centers.
Range: Spain
Status: Active
CIBERESP – Epidemiology and Public Health
Mission: to create a stable network research structure in this area to allow the promotion of research and technical activity in a horizontal field of human health and, thus, to establish the essential bases for the development of the Public Health policies of the different responsible administrations. of the National Health System. This requires the coordination, collaboration and strategic and economic management of research groups distributed throughout the geography.
Range: Spain
Status: Active
CIBERDEM – Diabetes and Associated Metabolic Diseases Network
Mission: Lead the research effort of excellence in diabetes and associated metabolic diseases, as well as accelerate the translation of scientific results into clinical practice to improve the health of the population and people with diabetes and metabolic diseases.
Range: Spain
Status: Active
CIBERCV – Cardiovascular Diseases
Mission: to develop cooperative actions of excellence in the double field of translational cardiovascular research and training. These actions are aimed at the exploitation, attraction and retention of talent, and must lead to the clarification of the mechanisms of cardiovascular disease and the benefits that can be transferred to the diagnosis, prevention, cure or palliation of talent. 'this pathology and its sequelae. They must also contribute to the prosperity of our society, helping to protect the health of our citizens, contributing to the generation of employment and supporting the development of the biomedical industry within our borders.
Range: Spain
Status: Active
CERCA - Ginys